
This study identified downregulated circulating exosomal miR‐363‐5p in breast cancer (BC) patients with lymph node (LN) metastasis. The miR‐363‐5p achieved high performance as a noninvasive predictor of LN metastasis and prognosis. The exosomal miR‐363‐5p inhibits metastatic properties and suppresses platelet‐derived growth factor B expression by targeting the 3′‐UTR. Our study provides a potential biomarker for LN staging and prognosis prediction of BC.
Like
Save
Share